Fig. 3From: Mesenchymal stromal cells as prophylaxis for graft-versus-host disease in haplo-identical hematopoietic stem cell transplantation recipients with severe aplastic anemia?—a systematic review and meta-analysisForest plots for the pooled 2-year overall survival (a MSCs group; b no MSCs group)Back to article page